<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2020, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 29 Jul 2019 16:15:00 -0500</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Hepion Pharmaceuticals Receives FDA Authorization to Proceed with IND Opening Study of CRV431 for NASH</title>
   <link>http://www.streetinsider.com/Press+Releases/Hepion+Pharmaceuticals+Receives+FDA+Authorization+to+Proceed+with+IND+Opening+Study+of+CRV431+for+NASH/15747687.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Hepion+Pharmaceuticals+Receives+FDA+Authorization+to+Proceed+with+IND+Opening+Study+of+CRV431+for+NASH/15747687.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Hepion+Pharmaceuticals+Receives+FDA+Authorization+to+Proceed+with+IND+Opening+Study+of+CRV431+for+NASH/15747687.html</guid>
   <pubDate>Mon, 29 Jul 2019 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEPA</category>
   	  </item>
  <item>
   <title>Hepion Pharmaceuticals Receives FDA Authorization to Proceed with IND Opening Study of CRV431 for NASH</title>
   <link>http://www.streetinsider.com/Press+Releases/Hepion+Pharmaceuticals+Receives+FDA+Authorization+to+Proceed+with+IND+Opening+Study+of+CRV431+for+NASH/15747687.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Hepion+Pharmaceuticals+Receives+FDA+Authorization+to+Proceed+with+IND+Opening+Study+of+CRV431+for+NASH/15747687.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Hepion+Pharmaceuticals+Receives+FDA+Authorization+to+Proceed+with+IND+Opening+Study+of+CRV431+for+NASH/15747687.html</guid>
   <pubDate>Mon, 29 Jul 2019 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEPA</category>
   	  </item>
  <item>
   <title>Hepion Pharmaceuticals Receives FDA Authorization to Proceed with IND Opening Study of CRV431 for NASH</title>
   <link>http://www.streetinsider.com/Press+Releases/Hepion+Pharmaceuticals+Receives+FDA+Authorization+to+Proceed+with+IND+Opening+Study+of+CRV431+for+NASH/15747687.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Hepion+Pharmaceuticals+Receives+FDA+Authorization+to+Proceed+with+IND+Opening+Study+of+CRV431+for+NASH/15747687.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Hepion+Pharmaceuticals+Receives+FDA+Authorization+to+Proceed+with+IND+Opening+Study+of+CRV431+for+NASH/15747687.html</guid>
   <pubDate>Mon, 29 Jul 2019 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEPA</category>
   	  </item>
  <item>
   <title>Hepion Pharmaceuticals Receives FDA Authorization to Proceed with IND Opening Study of CRV431 for NASH</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Hepion+Pharmaceuticals+Receives+FDA+Authorization+to+Proceed+with+IND+Opening+Study+of+CRV431+for+NASH/15747687.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Hepion+Pharmaceuticals+Receives+FDA+Authorization+to+Proceed+with+IND+Opening+Study+of+CRV431+for+NASH/15747687.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Hepion+Pharmaceuticals+Receives+FDA+Authorization+to+Proceed+with+IND+Opening+Study+of+CRV431+for+NASH/15747687.html</guid>
   <pubDate>Mon, 29 Jul 2019 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEPA</category>
   	  </item>
  <item>
   <title>Hepion Pharmaceuticals Receives FDA Authorization to Proceed with IND Opening Study of CRV431 for NASH</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Hepion+Pharmaceuticals+Receives+FDA+Authorization+to+Proceed+with+IND+Opening+Study+of+CRV431+for+NASH/15747687.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Hepion+Pharmaceuticals+Receives+FDA+Authorization+to+Proceed+with+IND+Opening+Study+of+CRV431+for+NASH/15747687.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Hepion+Pharmaceuticals+Receives+FDA+Authorization+to+Proceed+with+IND+Opening+Study+of+CRV431+for+NASH/15747687.html</guid>
   <pubDate>Mon, 29 Jul 2019 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEPA</category>
   	  </item>
  <item>
   <title>Hepion Pharmaceuticals Receives FDA Authorization to Proceed with IND Opening Study of CRV431 for NASH</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Hepion+Pharmaceuticals+Receives+FDA+Authorization+to+Proceed+with+IND+Opening+Study+of+CRV431+for+NASH/15747687.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Hepion+Pharmaceuticals+Receives+FDA+Authorization+to+Proceed+with+IND+Opening+Study+of+CRV431+for+NASH/15747687.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Hepion+Pharmaceuticals+Receives+FDA+Authorization+to+Proceed+with+IND+Opening+Study+of+CRV431+for+NASH/15747687.html</guid>
   <pubDate>Mon, 29 Jul 2019 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEPA</category>
   	  </item>
  <item>
   <title>Form  8-K        ContraVir Pharmaceutical  For: Jul 18</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ContraVir+Pharmaceutical++For%3A+Jul+18/15725715.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ContraVir+Pharmaceutical++For%3A+Jul+18/15725715.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ContraVir+Pharmaceutical++For%3A+Jul+18/15725715.html</guid>
   <pubDate>Tue, 23 Jul 2019 08:01:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	  </item>
  <item>
   <title>ContraVir Pharmaceuticals Announces Name Change to Hepion Pharmaceuticals, Inc.; Trading Symbol Change to “HEPA”</title>
   <link>http://www.streetinsider.com/Press+Releases/ContraVir+Pharmaceuticals+Announces+Name+Change+to+Hepion+Pharmaceuticals%2C+Inc.%3B+Trading+Symbol+Change+to+%E2%80%9CHEPA%E2%80%9D/15723066.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/ContraVir+Pharmaceuticals+Announces+Name+Change+to+Hepion+Pharmaceuticals%2C+Inc.%3B+Trading+Symbol+Change+to+%E2%80%9CHEPA%E2%80%9D/15723066.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ContraVir+Pharmaceuticals+Announces+Name+Change+to+Hepion+Pharmaceuticals%2C+Inc.%3B+Trading+Symbol+Change+to+%E2%80%9CHEPA%E2%80%9D/15723066.html</guid>
   <pubDate>Mon, 22 Jul 2019 14:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEPA</category>
   	  </item>
  <item>
   <title>ContraVir Pharmaceuticals Announces Name Change to Hepion Pharmaceuticals, Inc.; Trading Symbol Change to “HEPA”</title>
   <link>http://www.streetinsider.com/Press+Releases/ContraVir+Pharmaceuticals+Announces+Name+Change+to+Hepion+Pharmaceuticals%2C+Inc.%3B+Trading+Symbol+Change+to+%E2%80%9CHEPA%E2%80%9D/15723066.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/ContraVir+Pharmaceuticals+Announces+Name+Change+to+Hepion+Pharmaceuticals%2C+Inc.%3B+Trading+Symbol+Change+to+%E2%80%9CHEPA%E2%80%9D/15723066.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ContraVir+Pharmaceuticals+Announces+Name+Change+to+Hepion+Pharmaceuticals%2C+Inc.%3B+Trading+Symbol+Change+to+%E2%80%9CHEPA%E2%80%9D/15723066.html</guid>
   <pubDate>Mon, 22 Jul 2019 14:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HEPA</category>
   	  </item>
  <item>
   <title>Form  SC 13G     ContraVir Pharmaceutical               Filed by: Anson Funds Management LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SC+13G+++++ContraVir+Pharmaceutical+++++++++++++++Filed+by%3A+Anson+Funds+Management+LP/15657799.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++SC+13G+++++ContraVir+Pharmaceutical+++++++++++++++Filed+by%3A+Anson+Funds+Management+LP/15657799.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SC+13G+++++ContraVir+Pharmaceutical+++++++++++++++Filed+by%3A+Anson+Funds+Management+LP/15657799.html</guid>
   <pubDate>Fri, 28 Jun 2019 08:43:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	  </item>
  <item>
   <title>Form  SC 13G     ContraVir Pharmaceutical               Filed by: CVI Investments, Inc.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SC+13G+++++ContraVir+Pharmaceutical+++++++++++++++Filed+by%3A+CVI+Investments%2C+Inc./15652893.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++SC+13G+++++ContraVir+Pharmaceutical+++++++++++++++Filed+by%3A+CVI+Investments%2C+Inc./15652893.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SC+13G+++++ContraVir+Pharmaceutical+++++++++++++++Filed+by%3A+CVI+Investments%2C+Inc./15652893.html</guid>
   <pubDate>Thu, 27 Jun 2019 09:54:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	  </item>
  <item>
   <title>ContraVir Pharma (CTRV) Submits IND Application for CRV431 for NASH</title>
   <link>http://www.streetinsider.com/Corporate+News/ContraVir+Pharma+%28CTRV%29+Submits+IND+Application+for+CRV431+for+NASH/15652163.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/ContraVir+Pharma+%28CTRV%29+Submits+IND+Application+for+CRV431+for+NASH/15652163.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/ContraVir+Pharma+%28CTRV%29+Submits+IND+Application+for+CRV431+for+NASH/15652163.html</guid>
   <pubDate>Thu, 27 Jun 2019 08:05:44 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	  </item>
  <item>
   <title>ContraVir Pharma (CTRV) Submits IND Application for CRV431 for NASH</title>
   <link>http://www.streetinsider.com/FDA/ContraVir+Pharma+%28CTRV%29+Submits+IND+Application+for+CRV431+for+NASH/15652163.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/FDA/ContraVir+Pharma+%28CTRV%29+Submits+IND+Application+for+CRV431+for+NASH/15652163.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/ContraVir+Pharma+%28CTRV%29+Submits+IND+Application+for+CRV431+for+NASH/15652163.html</guid>
   <pubDate>Thu, 27 Jun 2019 08:05:44 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	  </item>
  <item>
   <title>ContraVir Pharma (CTRV) Submits IND Application for CRV431 for NASH</title>
   <link>http://www.streetinsider.com/Management+Comments/ContraVir+Pharma+%28CTRV%29+Submits+IND+Application+for+CRV431+for+NASH/15652163.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/ContraVir+Pharma+%28CTRV%29+Submits+IND+Application+for+CRV431+for+NASH/15652163.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/ContraVir+Pharma+%28CTRV%29+Submits+IND+Application+for+CRV431+for+NASH/15652163.html</guid>
   <pubDate>Thu, 27 Jun 2019 08:05:44 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	  </item>
  <item>
   <title>ContraVir Pharmaceuticals Submits IND Application for CRV431 for NASH</title>
   <link>http://www.streetinsider.com/Press+Releases/ContraVir+Pharmaceuticals+Submits+IND+Application+for+CRV431+for+NASH/15652109.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/ContraVir+Pharmaceuticals+Submits+IND+Application+for+CRV431+for+NASH/15652109.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ContraVir+Pharmaceuticals+Submits+IND+Application+for+CRV431+for+NASH/15652109.html</guid>
   <pubDate>Thu, 27 Jun 2019 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14817147</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	  </item>
  <item>
   <title>ContraVir Pharmaceuticals Submits IND Application for CRV431 for NASH</title>
   <link>http://www.streetinsider.com/Press+Releases/ContraVir+Pharmaceuticals+Submits+IND+Application+for+CRV431+for+NASH/15652109.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/ContraVir+Pharmaceuticals+Submits+IND+Application+for+CRV431+for+NASH/15652109.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ContraVir+Pharmaceuticals+Submits+IND+Application+for+CRV431+for+NASH/15652109.html</guid>
   <pubDate>Thu, 27 Jun 2019 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14817147</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	  </item>
  <item>
   <title>ContraVir Pharmaceuticals Submits IND Application for CRV431 for NASH</title>
   <link>http://www.streetinsider.com/Press+Releases/ContraVir+Pharmaceuticals+Submits+IND+Application+for+CRV431+for+NASH/15652109.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/ContraVir+Pharmaceuticals+Submits+IND+Application+for+CRV431+for+NASH/15652109.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ContraVir+Pharmaceuticals+Submits+IND+Application+for+CRV431+for+NASH/15652109.html</guid>
   <pubDate>Thu, 27 Jun 2019 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14817147</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	  </item>
  <item>
   <title>ContraVir Pharma (CTRV) Receives Positive FDA Response to CRV431 Pre-IND Package for NASH</title>
   <link>http://www.streetinsider.com/Corporate+News/ContraVir+Pharma+%28CTRV%29+Receives+Positive+FDA+Response+to+CRV431+Pre-IND+Package+for+NASH/15632565.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/ContraVir+Pharma+%28CTRV%29+Receives+Positive+FDA+Response+to+CRV431+Pre-IND+Package+for+NASH/15632565.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/ContraVir+Pharma+%28CTRV%29+Receives+Positive+FDA+Response+to+CRV431+Pre-IND+Package+for+NASH/15632565.html</guid>
   <pubDate>Thu, 20 Jun 2019 16:31:16 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	  </item>
  <item>
   <title>ContraVir Pharma (CTRV) Receives Positive FDA Response to CRV431 Pre-IND Package for NASH</title>
   <link>http://www.streetinsider.com/FDA/ContraVir+Pharma+%28CTRV%29+Receives+Positive+FDA+Response+to+CRV431+Pre-IND+Package+for+NASH/15632565.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/FDA/ContraVir+Pharma+%28CTRV%29+Receives+Positive+FDA+Response+to+CRV431+Pre-IND+Package+for+NASH/15632565.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/ContraVir+Pharma+%28CTRV%29+Receives+Positive+FDA+Response+to+CRV431+Pre-IND+Package+for+NASH/15632565.html</guid>
   <pubDate>Thu, 20 Jun 2019 16:31:16 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	  </item>
  <item>
   <title>ContraVir Pharma (CTRV) Receives Positive FDA Response to CRV431 Pre-IND Package for NASH</title>
   <link>http://www.streetinsider.com/Management+Comments/ContraVir+Pharma+%28CTRV%29+Receives+Positive+FDA+Response+to+CRV431+Pre-IND+Package+for+NASH/15632565.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/ContraVir+Pharma+%28CTRV%29+Receives+Positive+FDA+Response+to+CRV431+Pre-IND+Package+for+NASH/15632565.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/ContraVir+Pharma+%28CTRV%29+Receives+Positive+FDA+Response+to+CRV431+Pre-IND+Package+for+NASH/15632565.html</guid>
   <pubDate>Thu, 20 Jun 2019 16:31:16 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	  </item>
  <item>
   <title>Form  8-K        ContraVir Pharmaceutical  For: Jun 18</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ContraVir+Pharmaceutical++For%3A+Jun+18/15632560.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ContraVir+Pharmaceutical++For%3A+Jun+18/15632560.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ContraVir+Pharmaceutical++For%3A+Jun+18/15632560.html</guid>
   <pubDate>Thu, 20 Jun 2019 16:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	  </item>
  <item>
   <title>ContraVir Pharmaceuticals Receives Positive FDA Response to CRV431 Pre-IND Package for NASH</title>
   <link>http://www.streetinsider.com/Press+Releases/ContraVir+Pharmaceuticals+Receives+Positive+FDA+Response+to+CRV431+Pre-IND+Package+for+NASH/15632557.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/ContraVir+Pharmaceuticals+Receives+Positive+FDA+Response+to+CRV431+Pre-IND+Package+for+NASH/15632557.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ContraVir+Pharmaceuticals+Receives+Positive+FDA+Response+to+CRV431+Pre-IND+Package+for+NASH/15632557.html</guid>
   <pubDate>Thu, 20 Jun 2019 16:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	  </item>
  <item>
   <title>ContraVir Pharmaceuticals Receives Positive FDA Response to CRV431 Pre-IND Package for NASH</title>
   <link>http://www.streetinsider.com/Press+Releases/ContraVir+Pharmaceuticals+Receives+Positive+FDA+Response+to+CRV431+Pre-IND+Package+for+NASH/15632557.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/ContraVir+Pharmaceuticals+Receives+Positive+FDA+Response+to+CRV431+Pre-IND+Package+for+NASH/15632557.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ContraVir+Pharmaceuticals+Receives+Positive+FDA+Response+to+CRV431+Pre-IND+Package+for+NASH/15632557.html</guid>
   <pubDate>Thu, 20 Jun 2019 16:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTRV</category>
   	  </item>
 </channel>
</rss>
